Mariano Marrodan , Carolina I. Perez Arana , Ricardo J. Kirchner , Francisco J. Varela , Gabriela I. Orzuza , Angeles Schteinschnaider , Miriam G. Chaderevian , Cristina Vita , Mauricio F. Farez , Jorge Correale
{"title":"抗nmdar脑炎贯穿整个生命周期:来自拉丁美洲队列的临床、电生理和预后见解。","authors":"Mariano Marrodan , Carolina I. Perez Arana , Ricardo J. Kirchner , Francisco J. Varela , Gabriela I. Orzuza , Angeles Schteinschnaider , Miriam G. Chaderevian , Cristina Vita , Mauricio F. Farez , Jorge Correale","doi":"10.1016/j.jneuroim.2025.578766","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objectives</h3><div>Anti-N-Methyl-<span>d</span>-aspartate receptor encephalitis (NMDARE) is the most prevalent autoimmune encephalitis, primarily affecting young females. Its clinical heterogeneity, particularly in underrepresented populations, poses diagnostic and therapeutic challenges. Epidemiological data from Latin America remain limited. This study aimed to characterise the demographic, clinical, and neuroimaging features of NMDARE in Latin American tertiary centres, with a focus on age-related differences.</div></div><div><h3>Methods</h3><div>A retrospective cohort study included NMDARE cases between January 2016 and December 2024. Inclusion criteria required anti-NMDAR antibody positivity in CSF and/or serum. Demographic, clinical, and paraclinical data were systematically collected. Comparisons between paediatric (<18 years) and adult (≥18 years) patients were conducted using appropriate statistical tests.</div></div><div><h3>Results</h3><div>Of 1026 screened patients, 58 tested positive for anti-NMDAR antibodies, and 49 met inclusion criteria. Female predominance was higher among adults (61.5 % vs. 30.4 %; <em>p</em> = 0.03). Adults more frequently presented with confusion (57.7 % vs. 13 %; <em>p</em> = 0.003), mood disturbances (61.5 % vs. 26.1 %; p = 0.03), cognitive impairment (76.9 % vs. 36.1 %; <em>p</em> = 0.001), and dysautonomia (19.2 % vs. 0 %; <em>p</em> = 0.04). Speech disturbances (56.5 % vs. 34.6 %; <em>p</em> = 0.02), movement disorders (56.5 % vs 34.6 %, <em>p</em> = 0.06), and EEG abnormalities (69.6 % vs. 42.3 %; <em>p</em> = 0.01) were more frequent in paediatric patients. CSF pleocytosis was independently associated with ICU admission (OR = 11, p = 0.01). Relapse occurred in 10 % of cases.</div></div><div><h3>Discussion</h3><div>In this Latin American cohort, NMDARE presents distinct age-dependent clinical profiles. While existing diagnostic criteria are broadly applicable, awareness of age-specific features—particularly psychiatric symptoms in adults and EEG abnormalities in children—may improve diagnostic accuracy and guide tailored management strategies. Larger cohort studies in other populations have reported different findings, underscoring the importance of regional studies and the need for additional research to validate and generalize these results.</div></div>","PeriodicalId":16671,"journal":{"name":"Journal of neuroimmunology","volume":"409 ","pages":"Article 578766"},"PeriodicalIF":2.5000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-NMDAR encephalitis across the lifespan: Clinical, electrophysiological, and prognostic insights from a Latin American cohort\",\"authors\":\"Mariano Marrodan , Carolina I. Perez Arana , Ricardo J. Kirchner , Francisco J. Varela , Gabriela I. Orzuza , Angeles Schteinschnaider , Miriam G. Chaderevian , Cristina Vita , Mauricio F. Farez , Jorge Correale\",\"doi\":\"10.1016/j.jneuroim.2025.578766\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objectives</h3><div>Anti-N-Methyl-<span>d</span>-aspartate receptor encephalitis (NMDARE) is the most prevalent autoimmune encephalitis, primarily affecting young females. Its clinical heterogeneity, particularly in underrepresented populations, poses diagnostic and therapeutic challenges. Epidemiological data from Latin America remain limited. This study aimed to characterise the demographic, clinical, and neuroimaging features of NMDARE in Latin American tertiary centres, with a focus on age-related differences.</div></div><div><h3>Methods</h3><div>A retrospective cohort study included NMDARE cases between January 2016 and December 2024. Inclusion criteria required anti-NMDAR antibody positivity in CSF and/or serum. Demographic, clinical, and paraclinical data were systematically collected. Comparisons between paediatric (<18 years) and adult (≥18 years) patients were conducted using appropriate statistical tests.</div></div><div><h3>Results</h3><div>Of 1026 screened patients, 58 tested positive for anti-NMDAR antibodies, and 49 met inclusion criteria. Female predominance was higher among adults (61.5 % vs. 30.4 %; <em>p</em> = 0.03). Adults more frequently presented with confusion (57.7 % vs. 13 %; <em>p</em> = 0.003), mood disturbances (61.5 % vs. 26.1 %; p = 0.03), cognitive impairment (76.9 % vs. 36.1 %; <em>p</em> = 0.001), and dysautonomia (19.2 % vs. 0 %; <em>p</em> = 0.04). Speech disturbances (56.5 % vs. 34.6 %; <em>p</em> = 0.02), movement disorders (56.5 % vs 34.6 %, <em>p</em> = 0.06), and EEG abnormalities (69.6 % vs. 42.3 %; <em>p</em> = 0.01) were more frequent in paediatric patients. CSF pleocytosis was independently associated with ICU admission (OR = 11, p = 0.01). Relapse occurred in 10 % of cases.</div></div><div><h3>Discussion</h3><div>In this Latin American cohort, NMDARE presents distinct age-dependent clinical profiles. While existing diagnostic criteria are broadly applicable, awareness of age-specific features—particularly psychiatric symptoms in adults and EEG abnormalities in children—may improve diagnostic accuracy and guide tailored management strategies. Larger cohort studies in other populations have reported different findings, underscoring the importance of regional studies and the need for additional research to validate and generalize these results.</div></div>\",\"PeriodicalId\":16671,\"journal\":{\"name\":\"Journal of neuroimmunology\",\"volume\":\"409 \",\"pages\":\"Article 578766\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuroimmunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165572825002474\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroimmunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165572825002474","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Anti-NMDAR encephalitis across the lifespan: Clinical, electrophysiological, and prognostic insights from a Latin American cohort
Background and objectives
Anti-N-Methyl-d-aspartate receptor encephalitis (NMDARE) is the most prevalent autoimmune encephalitis, primarily affecting young females. Its clinical heterogeneity, particularly in underrepresented populations, poses diagnostic and therapeutic challenges. Epidemiological data from Latin America remain limited. This study aimed to characterise the demographic, clinical, and neuroimaging features of NMDARE in Latin American tertiary centres, with a focus on age-related differences.
Methods
A retrospective cohort study included NMDARE cases between January 2016 and December 2024. Inclusion criteria required anti-NMDAR antibody positivity in CSF and/or serum. Demographic, clinical, and paraclinical data were systematically collected. Comparisons between paediatric (<18 years) and adult (≥18 years) patients were conducted using appropriate statistical tests.
Results
Of 1026 screened patients, 58 tested positive for anti-NMDAR antibodies, and 49 met inclusion criteria. Female predominance was higher among adults (61.5 % vs. 30.4 %; p = 0.03). Adults more frequently presented with confusion (57.7 % vs. 13 %; p = 0.003), mood disturbances (61.5 % vs. 26.1 %; p = 0.03), cognitive impairment (76.9 % vs. 36.1 %; p = 0.001), and dysautonomia (19.2 % vs. 0 %; p = 0.04). Speech disturbances (56.5 % vs. 34.6 %; p = 0.02), movement disorders (56.5 % vs 34.6 %, p = 0.06), and EEG abnormalities (69.6 % vs. 42.3 %; p = 0.01) were more frequent in paediatric patients. CSF pleocytosis was independently associated with ICU admission (OR = 11, p = 0.01). Relapse occurred in 10 % of cases.
Discussion
In this Latin American cohort, NMDARE presents distinct age-dependent clinical profiles. While existing diagnostic criteria are broadly applicable, awareness of age-specific features—particularly psychiatric symptoms in adults and EEG abnormalities in children—may improve diagnostic accuracy and guide tailored management strategies. Larger cohort studies in other populations have reported different findings, underscoring the importance of regional studies and the need for additional research to validate and generalize these results.
期刊介绍:
The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.